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ABSTRACT  
Purpose Spirituality has been associated with better cardiac autonomic balance, but its 
association with cardiovascular risk is not well studied. We examined whether more frequent 
private spiritual activity was associated with reduced cardiovascular risk in postmenopausal 
women enrolled in the Women’s Health Initiative Observational Study.  
Methods Frequency of private spiritual activity (prayer, Bible reading, and meditation) was self-
reported at year 5 of follow-up. Cardiovascular outcomes were centrally adjudicated, and 
cardiovascular risk was estimated from proportional hazards models.  
Results Final models included 43,708 women (mean age: 68.9±7.3; median follow-up: 7.0 
years) free of cardiac disease through year 5 of follow-up. In age-adjusted models private 
spiritual activity was associated with increased cardiovascular risk (HR: 1.16; CI 1.02, 1.31, 
weekly vs. never; 1.25; CI 1.11, 1.40, daily vs. never). In multivariate models adjusted for 
demographics, lifestyle, risk factors, and psychosocial factors, such association remained 
significant only in the group with daily activity (HR 1.16; CI: 1.03, 1.30). Subgroup analyses 
indicate this association may be driven by the presence of severe chronic diseases.   
Conclusion In aging women, higher frequency of private spiritual activity was associated with 
increased cardiovascular risk, likely reflecting a mobilization of spiritual resources in order to 
cope with aging and illness.  
 
Key words: women’s health, cardiovascular diseases, spirituality
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List of abbreviations and acronyms 
R/S = Religiosity/spirituality 
MESA=Multi Ethnic Study of Atherosclerosis 
SNS= Sympathetic Nervous System 
WHI= Women’s Health Initiative 
CVD= cardiovascular disease 
OS= Observational Study 
YR=year 
MET = Metabolic Equivalent of Task 
STROBE = STrengthening the Reporting of OBservational studies in Epidemiology 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 4 
Introduction 
There is increasing interest in the study of the relationship between religiosity/spirituality 
(R/S) and health, fostered by the finding that individuals who regularly attend religious services 
[1-9] have a reduction in overall mortality of almost 20%. The evidence for the possible 
association between R/S and reduced cardiovascular risk, however, is less consistent. Multiple 
prospective cohort and case-control studies [3, 9-12] have linked R/S with reduced 
cardiovascular mortality and morbidity. A cross-sectional study conducted in a rural population 
in India has shown that men participating in prayer and yoga had a lower prevalence of coronary 
heart disease after adjustment for coronary risk factors. [13] A composite R/S measure 
(frequency of service attendance, prayer and fasting) was inversely associated with acute 
coronary events in a recent case-control study [14] conducted in a predominantly Moslem and 
Christian population. On the other hand, other studies somewhat contradicted these results. 
Schnall [8] reported a lack of association between several self-reported measures of R/S 
(religious affiliation, frequency of service attendance, and religious coping) and cardiovascular 
mortality in a large population of postmenopausal women. More frequent service attendance, 
prayer or meditation, and higher daily spiritual experience (DSE) scores were not associated with 
reduced cardiovascular risk in a prospective cohort study involving more than five thousand 
healthy men and women enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA). [15] In 
a study of non-institutionalized older adults, Colantonio and colleagues reported that more 
frequent worship attendance was associated with a reduced risk of stroke in unadjusted models 
[16]; in adjusted models, however, this association was no longer significant. Another study 
conducted in myocardial infarction survivors with depression and low social support did not 
show an association between DSE scores, church attendance, or frequency of private spiritual 
activity and non-fatal cardiac events. [17]  
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The link between frequency of individual private spiritual practices such as prayer, 
meditation, and devotional reading and cardiovascular health has been less frequently 
investigated at the population level compared with the more public aspects of R/S, namely, 
religious services attendance. Practices such as prayer or meditation are particularly interesting 
because their association with cardiovascular risk is less likely to be affected by variables – such 
as social support – that are known confounders of the association between service attendance and 
cardiovascular outcomes. Furthermore, unlike service attendance, the physiological changes 
occurring during prayer and meditation have been extensively studied and consist in a decrease 
in sympathetic nervous system (SNS) activity, oxygen consumption, respiratory rate, and minute 
ventilation. [18] Prayer or mantra recitation have been linked with higher levels of cardiac 
autonomic control [19] and increased baro-reflex sensitivity, [20] conditions which in turn have 
been associated with a reduced risk of cardiac arrhythmias and cardiac mortality. [21-23] A 
reduction in the activity of the SNS may be beneficial for patients with coronary heart disease, as 
shown by findings of increased exercise tolerance and delayed onset of electrocardiographic 
signs of ischemia in patients enrolled in a transcendental meditation program. [24] Similar results 
were shown by Benson, who reported that meditation reduced the number of premature 
ventricular contractions in these patients. [25]   
The primary aim of this study was to evaluate whether private spiritual activity (prayer, 
meditation and reading of religious literature) is associated with a reduced incidence of fatal and 
non-fatal cardiovascular events in a large population of community-dwelling postmenopausal 
women enrolled in the Women’s Health Initiative (WHI) Observational Study (OS). The WHI 
affords a unique opportunity to evaluate this association given its large sample size as well as the 
adjudication of cardiovascular outcomes. Our study hypothesis was that women who report to 
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engage in private spiritual activity, compared to women reporting no spiritual activity, would 
have a reduced cardiovascular risk.  
The secondary aim was to assess whether the association may differ in women with a 
history of severe chronic diseases prior to the assessment of private spiritual activity compared to 
women without such history.  This analysis was undertaken in light of the important role of R/S, 
including private spiritual activity, in coping with serious illness. This is illustrated by the fact 
that the proportion of people with serious illnesses (e.g., cancer) who report praying for their 
health (77%) [26] may be double the proportion in the general population (43%) [27]. Further, 
there is evidence [28] that the association between private spiritual activity and cardiovascular 
risk may differ depending on whether such activity is a longstanding, lifelong behavior or rather 
an episodic phenomenon elicited in response to stressful events or illness.   
Despite the concerns raised in regard to the methodological limitations and lack of direct 
clinical applications of the research in this field, [29] the study of the role of R/S in the 
prevention of cardiovascular disease (CVD) may have important public health consequences if 
these practices are associated with a lower cardiovascular risk. [30]  
Methods 
The WHI included a set of randomized clinical trials and a separate OS. [29] The OS, the 
focus of this analysis, was a large prospective cohort study conducted in 93,676 postmenopausal 
women ineligible or unwilling to participate in the clinical trials. To be eligible women had to be 
50 to 79 years old, postmenopausal, and reside in the study recruitment area for at least 3 years 
following enrollment. Exclusion criteria were medical conditions predictive of a survival time of 
less than 3 years; conditions inconsistent with study participation such as alcoholism, drug 
dependency, mental illness, and dementia; and enrollment in another study. All participants 
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provided written informed consent according to the human subjects’ protection oversight at the 
40 participating sites. Recruitment (1994-1998) was conducted through mailings to eligible 
women from large mailing lists. Women were followed through 2005 as part of the original 
study and were offered the opportunity to continue for an additional 5 years in the WHI 
extension study. After obtaining informed consent, yearly questionnaires were administered by 
mail between 2005 and 2010.  
All OS participants underwent a baseline visit including physical measurements (height, 
weight, blood pressure, heart rate, waist and hip circumferences), blood specimen collection, a 
medication/supplement inventory, and completion of medical, family/ reproductive history, 
lifestyle/behavioral factors, and quality of life questionnaires. Follow-up included an on-site 
clinic visit three years after enrollment and annual mailings (a medical history update and 
questionnaires about lifestyle and dietary habits, demographics, hormone therapy, and 
psychosocial variables). The WHI OS outcomes were coronary heart disease, stroke, breast and 
colorectal cancer, osteoporotic fractures, diabetes, and total mortality.  
Study population 
Inclusion criteria for this secondary analysis were completion of the follow-up year 5 
(YR5) assessments, and absence of self-reported CVD and any cardiovascular events through 
YR5. Women who did not consent to the WHI extension study were censored at the date of last 
follow up. 
Exposure 
Time spent in private spiritual activity was assessed only at YR5 using a self-
administered questionnaire completed approximately 5 years (1999-2003) after enrollment in the 
original study asking how often the participant spent time in the following activities: prayer, 
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meditation, or reading religious literature during the prior year. The possible answers were never, 
a few times per year, a few times per month, about once a week, a few times per week, every 
day.  
Outcome  
The outcome for this analysis was fatal and non-fatal incident cardiovascular events, a 
cumulative endpoint defined as the first occurrence of non-fatal angina, myocardial infarction, 
congestive heart failure, coronary and carotid revascularization procedures, stroke, transient 
ischemic attack, peripheral arterial disease, and any adjudicated fatal cardiovascular event. 
Outcomes were identified by self-report on the medical history update or by reporting directly to 
clinic staff in the intervals between questionnaires. Centrally trained physicians adjudicated 
cardiovascular outcomes. [32] 
Covariates and other variables of interest 
Covariates were selected based on the literature and/or whether they were associated with 
frequency of private spiritual activity, cardiovascular events, or both. Whenever possible, we 
used information collected at the same time (YR5) as frequency of private spiritual activity. 
When variables had not been collected at YR5 we used covariates collected at YR3 or at 
baseline, whichever was closest in time. Except for body mass index (BMI) all covariates were 
collected by means of self-administered questionnaires and included: age; race/ethnicity 
(American Indian or Alaskan Native, Asian or Pacific Islander, Black or African-American, 
Hispanic/Latino, White, other); marital status (never married, married or in marriage-like 
relationship, widowed, divorced/separated); total years of education; and income (<$10,000; 
$10,000-19,999; $20,000-34,999; $35,000-49,999; $50,000–74,999; $75,000-99,999; $100,000-
149,000; >$150,000; does not know). Risk factors for CVD included history of hypertension and 
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diabetes; family history; smoking (ever, never, current); and BMI (weight in kilograms/ (height 
in meters) 2 calculated from direct measurements of height and weight performed at YR3). 
Cholesterol levels were not measured in the entire OS cohort so history of elevated cholesterol 
requiring pharmacological treatment was used as a proxy. Physical activity was calculated as 
energy expenditure from recreational physical activity (total MET-hours per week). Alcohol 
intake was measured as the number of servings of alcohol per week. Psychosocial variables 
included social support (from the Medical Outcomes Study); [33] physical functioning, 
emotional wellbeing and satisfaction with quality of life (Medical Outcome Study 36-Item 
Health Survey); [34] and depression (assessed using the shortened version of the Center for 
Epidemiological Studies Depression Scale). [35] 
History of severe chronic diseases was defined as a self-reported history of severe non-
cardiovascular co-morbidities before YR5 including diabetes, liver disease, dialysis, asthma, 
emphysema, lupus, Alzheimer disease, multiple sclerosis, Parkinson disease, amyotrophic lateral 
sclerosis as well as all adjudicated cancer outcomes (except non-melanoma skin cancers). 
Statistical analysis  
We used descriptive statistics to describe the baseline characteristics of the study 
population across categories of frequency of private spiritual activity. ANOVA F and 
independence χ2 tests were used to evaluate differences. The association between private 
spiritual activity (categorized as daily, once or more per week, less than once a week, and never) 
and cardiovascular events was evaluated using univariate and multivariate Cox proportional 
hazards regression models. We tested the assumption of the proportional hazard model by 
entering time dependent covariates into the model, and no violations were observed. Several 
models were fitted: unadjusted; adjusted for age only (model 1); adjusted also for demographic 
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variables (model 2); adjusted for all variables included in model 2 plus health behaviors (model 
3); adjusted for model 3 variables plus cardiovascular risk factors (model 4); adjusted for model 
4 variables and physical functioning, satisfaction with QOL, and social support (model 5). The 
final model included model 5 variables plus depression and emotional wellbeing (model 6). The 
need for a separate model including psychological variables arose because such variables may be 
on the causal pathway linking spirituality and survival.  In addition, we planned to conduct a 
subgroup analysis by presence/absence of history of severe chronic diseases prior to YR5. 
Results are presented as unadjusted and adjusted hazard ratios (HR) with 95% confidence 
intervals. P values <0.05 were considered significant. All statistical analyses were performed 
using SAS/STAT® version 9.2, SAS Institute, Cary, NC.   
Results 
Figure 1 (STROBE diagram) [36] shows the flow of patients through this study. Of the 
original cohort of 93,676 women enrolled in the OS, 61,370 met the eligibility criteria for this 
study.  Due to missing information on covariates included in multivariate models, 17,662 women 
were excluded from the final analysis. These women tended to be more frequently African 
American (9% vs. 5.4%) or Hispanic (5% vs. 2.8%), less educated (post- graduate education, 
28.3% vs. 34.6%) and more frequently current smokers (5% vs. 3.7%) compared to subjects 
included in the analysis, but had otherwise similar characteristics with regard to spiritual 
practices and cardiovascular events (no spiritual practice, excluded vs. included: 17.2% vs. 17.9); 
cardiovascular events: 6.3% vs. 5.8%).   
The baseline characteristics of the study population are shown in Table 1. Women with 
higher frequency of private spiritual activity tended to be older, less educated, of African 
American ancestry, widowed or never married, and of lower socio-economic status; they also 
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reported lower functional status scores. The prevalence of a diagnosis of a severe chronic disease 
prior to YR5 as well as of most risk factors for CVD was also higher in women reporting more 
frequent private spiritual activity. Specifically, these women were more frequently obese, used 
cholesterol-lowering drugs more often, had a history of hypertension or diabetes and reported 
lower levels of physical activity. The only exception among coronary risk factors was smoking, 
as women frequently engaging in private spiritual activity were less likely to be current or former 
smokers. Alcohol intake also was significantly lower in those with higher frequency of private 
spiritual activity.  Finally, women with more frequent spiritual practice had slightly better 
emotional wellbeing, higher social support and a slightly lower prevalence of depression and 
antidepressants use.  
The median duration of follow-up was 7 years, during which 2,554 cardiovascular events 
were observed (402 fatal). Age-adjusted models (Table 2, Model 1) showed that women who 
reported weekly and daily spiritual practice had a higher risk of cardiovascular events compared 
to women who never engaged in such activity (HR: 1.16; CI 1.02, 1.31, weekly vs. never; 1.25; 
CI 1.11, 1.40, daily vs. never). In a series of models that further adjusted for other demographic 
factors (model 2), lifestyle habits (model 3), and cardiovascular risk factors (model 4), women 
who reported daily private spiritual activity had a significantly increased risk for cardiovascular 
events (HR in the fully adjusted model 1.16, CI 1.03, 1.30) compared to women who did not 
reported such activity. Further adjustment for psychosocial measures (model 5) and depression 
and emotional wellbeing (model 6) did not modify these associations. We also fitted a model 
adjusting for presence/absence of severe chronic diseases in addition to the variables included in 
model 2 (age, ethnicity, marital status, income, and education), but the association between 
cardiovascular events and spiritual practice was not altered (HR: 1.08; CI 0.95, 1.23, weekly vs. 
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never; 1.13; CI 1.01, 1.27, daily vs. never). Finally, trend analysis showed that the risk of 
cardiovascular events increased with rising frequency of private spiritual activity (p for trend = 
0.010).  
Subgroup analysis 
Table 3 and Figure 2 show the results of the subgroup analysis by presence/absence of 
self-reported severe chronic diseases before YR5. Results indicate that the presence of severe 
chronic diseases was not an effect modifier (p= 0.6449).  
Discussion 
In previous population-based studies more frequent worship participation [3, 10] or, 
among Jews, adherence to orthodox practices and teachings [11, 12] were found to be associated 
with a reduced cardiovascular risk.  In our study of a large population of community–dwelling 
postmenopausal women, however, when we focused our attention on frequency of meditation, 
prayer or reading of religious texts, we found that this dimension of R/S was not associated with 
a reduced cardiovascular risk and in fact women reporting daily private spiritual activity had a 
higher risk of cardiovascular events compared to women who reported no private spiritual 
activity.  
The present study was designed to follow-up on the findings of a previous investigation 
conducted in the WHI-OS, [8] which did not detect an association between baseline measures of 
R/S and cardiovascular risk; these measures however did not include private spiritual activity. 
The relationship between multiple measures of R/S (worship attendance, prayer, and DSE 
scores) and cardiovascular risk factors and events has been studied among more than 5,000 
participants aged 45-84 in the MESA study. [15] As in the present study, higher levels of R/S, 
including prayer, were associated with greater risk of obesity and decreased risk of drinking and 
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smoking. Unlike the results reported here, among the MESA participants there was no significant 
association between frequency of prayer and cardiovascular risk.  Our study, however, had a 
larger sample size and a longer duration of follow-up; in addition, even in the MESA analysis, 
the point estimate in the group with daily private spiritual activity, although not significant, 
indicated an increased risk of cardiovascular events in the more religiously involved.  
A possible explanation for our findings would be confounding by the presence of severe 
chronic co-morbidities; in fact, the prevalence of severe chronic co-morbidities prior to YR5 was 
associated with a higher frequency of private spiritual activity (Table 1). In multivariate models 
however, the presence of severe chronic disease was not a confounder. Although the interaction 
term was not significant, the results of the stratified analysis nevertheless suggest that women 
with a prior diagnosis of severe chronic diseases likely drive the association between private 
spiritual activity and increased cardiovascular risk. Similar findings have been reported in 
another study conducted in an elderly population [28] in which the protective association 
between private spiritual activity and reduced overall mortality was detected only in individuals 
without impairment in activities of daily living, while it was not detected in the cohort reporting 
such condition. 
Our results are not consistent with some of the previously published studies indicating 
that R/S is associated with a lower cardiovascular risk. [9] It appears, however, that our 
knowledge about the link between R/S and cardiovascular health is far from being conclusive for 
several reasons. For example, studies that have detected a protective association between R/S 
and cardiovascular risk measured very different aspects of the R/S experience. Some researchers 
measured worship attendance only [3, 10] while others measured self-reported religiosity within 
specific religious groups. [1, 11, 12] Studies also differed as to whether they adjusted for 
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coronary risk factors (i.e. diabetes, high cholesterol) and other variables that may confound the 
association between R/S and cardiovascular mortality.  The only studies extensively adjusting for 
coronary risk factors and reporting an association between R/S (defined as being orthodox vs. 
secular) and reduced risk of cardiovascular mortality or acute myocardial infarction were 
conducted in a Jewish population in Israel. [1, 11, 12] Orthodox Judaism, however, is somewhat 
unique in that it regulates every aspect of life, [37, 38] thus raising the question of whether these 
results are generalizable to other religious affiliations. The populations studied in other 
investigations were also heterogeneous with regard to their age and health status, with protective 
associations between R/S and cardiovascular risk usually shown in younger and healthier 
populations, [3, 10, 12, 13] but not in older persons with concomitant diseases. [8, 9, 16, 17] The 
direction and the magnitude of the association between R/S and cardiovascular risk may change 
depending on whether the exposure began in healthy individuals and early in life as opposed to a 
later stage, when individuals may turn to religion as a coping mechanism in the face of declining 
health and advancing age. [28, 39] Finally, the duration of follow-up differed greatly among 
studies; studies reporting a protective effect usually had a longer follow-up duration. [3, 10, 11] 
This study has several strengths: first, a relatively long duration of follow-up; second, 
extensive adjustment for coronary risk factors, demographic and psychosocial variables; third, a 
relatively understudied population (women); and fourth, the validation of cardiovascular 
outcomes. The limitations of this analysis include the assessment of private spiritual activity as 
an aggregate only, with the resulting inability to assess associations between specific activities 
(i.e. meditation and/or prayer vs. reading of religious texts) and cardiovascular events; and the 
collection of private spiritual activity data only at YR5. Furthermore, some covariates were not 
collected at the same time point (YR5) as the spirituality activity assessment, and we had to use 
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baseline or YR3 covariates. Residual confounding (in particular regarding coronary risk factors 
such as blood pressure and serum lipid levels that were not directly measured) as well as 
selection bias (due to the large number of women excluded) are additional limitations of this 
analysis. Also, we cannot rule out the possible contribution of survivor bias (e.g., women with 
lower levels of private spirituality activity not surviving long enough to be included in the 
current analysis) to our findings. Finally, results are not generalizable to younger or male 
populations, and to women that were excluded from participation in the parent study (i.e. women 
with alcoholism, drug dependency, mental illness, and dementia).  
 In conclusion, our results confirm recent indications that higher R/S does not prevent 
fatal and non-fatal cardiovascular events, [8, 15] at least in older female populations. Further 
research involving younger and healthier populations is needed to achieve a better understanding 
of the role of R/S in the prevention of cardiovascular risk.  
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Table 1 – Characteristics of the study population, by frequency of private spiritual activity 
 Private spiritual activity 
 
 
Overall Never < Once per Week 
Once or 
more per 
Week 
Daily P 
 43,708 7,829 (17.9) 
9,109 
(20.9) 
10,810 
(24.7) 
15,960 
(36.5)  
Age in years (mean (SD), 
year 5) 
67.96 
(7.08) 
67.84 
(7.30) 
67.53 
(7.11) 
67.52 
(6.95) 
68.58 
(6.99) <0.0001
a)
 
Ethnicity       
American Indian or 
Alaskan Native 139 (0.3) 14 (0.2) 27 (0.3) 33 (0.3) 65 (0.4) <0.0001
b)
 
Asian or Pacific 
Islander 
1,376 
(3.2) 347 (4.4) 364 (4.0) 274 (2.5) 391 (2.5)  
Black or African-
American 
2,380 
(5.5) 114 (1.5) 300 (3.3) 630 (5.8) 
1,336 
(8.4)  
Hispanic/Latino 1,217 (2.8) 156 (2.0) 206 (2.3) 285 (2.6) 570 (3.6)  
White not Hispanic 38,179 (87.4) 
7,120 
(90.9) 
8,127 
(89.2) 
9,515 
(88.0) 
13,417 
(84.1)  
Other 417 (1.0) 78 (1.0) 85 (0.9) 73 (0.7) 181 (1.1)  
Years of education, (mean 
(SD)) 15.1 (2.5) 15.6 (2.5) 15.3 (2.4) 15.0 (2.4) 14.8 (2.5) <0.0001
b)
 
Marital status, (year 5)       
Never married 1,978 (4.5) 352 (4.5) 380 (4.2) 413 (3.8) 833 (5.2) <0.0001
b)
 
Divorced or separated 6,069 (13.9) 
1,262 
(16.1) 
1,420 
(15.6) 
1,414 
(13.1) 
1,973 
(12.4)  
Widowed 8,292 (19.0) 
1,255 
(16.0) 
1,528 
(16.8) 
1,975 
(18.3) 
3,534 
(22.1)  
Presently married 26,159 (59.9) 
4,614 
(58.9) 
5,447 
(59.8) 
6,766 
(62.6) 
9,332 
(58.5)  
Living in a marriage-
like relationship 
1,210 
(2.8) 346 (4.4) 334 (3.7) 242 (2.2) 288 (1.8)  
Income, baseline       
<$10,000 990 (2.3) 160 (2.0) 147 (1.6) 217 (2.0) 466 (2.9) <0.0001b) 
$10,000-$19,999 3,675 (8.4) 496 (6.3) 598 (6.6) 847 (7.8) 
1,734 
(10.9)  
$20,000-$34,999 9,265 (21.2) 
1,288 
(16.5) 
1,743 
(19.1) 
2,337 
(21.6) 
3,897 
(24.4)  
$35,000-$49,999 8,795 (20.1) 
1,392 
(17.8) 
1,761 
(19.3) 
2,248 
(20.8) 
3,394 
(21.3)  
$50,000-$74,999 9,530 (21.8) 
1,741 
(22.2) 
2,045 
(22.5) 
2,462 
(22.8) 
3,282 
(20.6)  
$75,000-$99,999 4,723 (10.8) 
1,051 
(13.4) 
1,133 
(12.4) 
1,140 
(10.6) 
1,399 
(8.8)  
$100,000-$149,999 3,625 (8.3) 912 (11.7) 936 (10.3) 848 (7.8) 929 (5.8)  
≥$150,000 2,055 (4.7) 641 (8.2) 537 (5.9) 470 (4.4) 407 (2.6)  
Don’t Know 1,050 (2.4) 148 (1.9) 209 (2.3) 241 (2.2) 452 (2.8)  
BMI, year 31       
Normal <25 18,258 (41.8) 
3,858 
(49.3) 
3,951 
(43.4) 
4,107 
(38.0) 
6,342 
(39.7) <0.0001
b)
 
Overweight 25-<30 15,174 (34.7) 
2,568 
(32.8) 
3,159 
(34.7) 
3,926 
(36.3) 
5,521 
(34.6)  
Obese >=30 10,276 (23.5) 
1,403 
(17.9) 
1, 99 
(22.0) 
2,777 
(25.7) 
4,097 
(25.7)  
D p ession, year 31 3,653 8 4 653 (8.3) 757 (8.3) 991 (9.2) 
1,252 
7 8 0.0020
 b)
 
Antidepressant use, year 32 3,842 (8.8) 692 (8.9) 810 (8.9) 
1,022 
(9.5) 
1,318 
(8.3) 0.0090
 b)
 
Physical activity, year 5  
(MET-hours/week; mean 
(SD)) 
14.25
(14.01) 
15.92 
(14.99) 
14.88 
(14.09) 
13.62 
(13.43) 
13.50 
(13.75) <0.0001
c)
 
High cholesterol requiring 
pills ever, baseline 
5,095 
(11.7) 845 (10.8) 
1,043 
(11.5) 
1,279 
(11.8) 
1,928 
(12.1) 0.0274
 b)
 
History of hypertension, 
year 5 
15,621 
(35.7) 
2,416 
(30.9) 
3,143 
(34.5) 
3,952 
(36.6) 
6,110 
(38.3) <0.0001
b)
 
Diabetes, year 5 1,996 (4.6) 289 (3.7) 368 (4.0) 516 (4.8) 823 (5.2) <0.0001
b)
 
Relative had heart attack, 
baseline 
21,882 
(50.1) 
3,736 
(47.7) 
4,515 
(49.6) 
5,527 
(51.1) 
8,104 
(50.8) <0.0001
b)
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Values are n (%) unless otherwise specified 
All variables collected at year 5 of follow-up unless otherwise specified 
a) ANOVA, b) Chi-square, c) Kruskal-Wallis 
Depression = Center of Epidemiological Studies (CES-D) score >.06 
BMI=body mass index (kg/m2); MET=metabolic equivalent tasks 
Social Support, baseline 
(mean (SD)) 
36.67 
(7.37) 
36.26 
(7.75) 
36.23 
(7.40) 
36.59 
(7.15) 
37.18 
(7.26) <0.0001
c)
 
Physical Functioning, year 
3  (mean (SD)) 
82.13 
(19.62) 
84.21 
(18.76) 
83.14 
(18.94) 
81.76 
(19.42) 
80.78 
(20.41) <0.0001
c)
 
Emotional Well-being, 
year 3 (mean (SD)) 
81.37 
(13.91) 
81.03 
(14.50) 
80.72 
(14.08) 
80.94 
(13.82) 
82.20 
(13.52) <0.0001
c)
 
Satisfaction with quality of 
life, year 3 (mean (SD)) 
8.31 
(1.78) 
8.22 
(1.84) 
8.21 
(1.80) 
8.28 
(1.77) 
8.44 
(1.73) <0.0001
c)
 
Smoking status (year 5)       
Never smoked 22,748 (52.1) 
3,430 
(43.8) 
4,396 
(48.3) 
5,722 
(52.9) 
9,200 
(57.6) <0.0001
b)
 
Past smoker 19,336 (44.2) 
4,017 
(51.3) 
4,357 
(47.8) 
4,700 
(43.5) 
6,262 
(39.2)  
Current Smoker 1,624 (3.7) 382 (4.9) 356 (3.9) 388 (3.6) 498 (3.1)  
Alcohol servings per 
week, year 3 (mean (SD)) 
2.67 
(5.23) 
3.84 
(6.65) 
3.08 
(5.50) 
2.48 
(4.71) 
1.99 
(4.45) <0.0001
c)
 
Diagnosis of severe 
chronic diseases prior to 
year 5  
14,708 
(33.7) 
2,472 
(16.8) 
2,937 
(20.0) 
3,597 
(24.5) 
5,702 
(38.8) <0.0001
b)
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Table 2 – Unadjusted and adjusted hazard ratios of fatal and non-fatal cardiovascular events by 
frequency of private spiritual activity 
 
Private spiritual activity 
 
 
 
Never 
(REF.) 
< Once per 
Week 
Once or more 
per Week Daily 
P for 
trend 
Cardiovascular events 
n (%) 
408 (5.2) 499 (5.5) 612 (5.7) 1035 (6.5)  
Unadjusted HR 1.00 1.06 (0.93-1.21) 1.12 (0.99-1.27) 1.31 (1.17-1.47) <.001 
Model 1 HR 1.00 1.10 (0.96-1.25) 1.16 (1.02-1.31) 1.25 (1.11-1.40) <.001 
Model 2 HR 1.00 1.06 (0.93-1.21) 1.08 (0.96-1.23) 1.14 (1.01-1.28) 0.025 
Model 3 HR 1.00 1.07 (0.94-1.22) 1.10 (0.97-1.25) 1.17 (1.04-1.31) 0.008 
Model 4 HR 1.00 1.05 (0.92-1.19) 1.06 (0.94-1.21) 1.14 (1.01-1.28) 0.022 
Model 5 HR 1.00 1.05 (0.92-1.19) 1.07 (0.94-1.21) 1.15 (1.03-1.30) 0.011 
Model 6 HR 1.00 1.05 (0.92-1.19) 1.07 (0.94-1.21) 1.16 (1.03-1.30) 0.010 
 
The analysis included women with complete data, cardiovascular mortality and cardiovascular 
events (n=43,708) 
Hazard ratios (HR) are reported with 95% confidence intervals.  
Model 1 – age-adjusted  
Model 2 – adjusted for age, ethnicity, marital status, income, and education 
Model 3 – model 2 plus physical activity (MET-hours), smoking status, alcohol servings/week  
Model 4 – model 3 plus BMI, high cholesterol, hypertension, diabetes, and family history of 
myocardial infarction  
Model 5 – model 4 plus physical functioning, satisfaction with quality of life, social support  
Model 6 – model 5 plus CES-D and emotional well-being scores 
 
Cardiovascular events = cumulative endpoint (angina, coronary and carotid revascularization, 
stroke, transient ischemic attack, congestive heart failure, peripheral arterial disease, and any 
adjudicated cardiovascular death) 
CES-D= Center for Epidemiologic Studies depression scale 
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Figure legends 
 
Figure 1. STROBE diagram.  
CV=cardiovascular; WHI-OS=Women’s Health Initiative Observational Study 
 
 
Figure 2.  
Adjusted associations between private spiritual activity and fatal and non-fatal cardiovascular 
events, overall and by presence/absence of severe chronic diseases prior to YR5. Severe chronic 
diseases included any cancer (except non-melanoma skin cancer), diabetes, liver disease, 
dialysis, asthma, emphysema, lupus, Alzheimer disease, multiple sclerosis, Parkinson disease, 
ALS 
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Table 3. Adjusted hazard ratios of cardiovascular events by frequency of spiritual practice, 
results of the subgroup analysis by presence/absence of chronic disease prior to YR5 
   
Private spiritual activity  
 
n 
CV events 
n (%) Never  
< Once per 
Week 
Once or more 
per week Daily 
   REF HR (95% CI) HR (95% CI) HR (95% CI) 
       
No CDH  29,000 1,469 (5.1) 1.00 1.06 (0.90-1.26) 1.05 (0.89-1.24) 1.08 (0.93-1.26) 
CDH   14,708 1,085 (7.4) 1.00 1.06 (0.86-1.31) 1.12 (0.92-1.37) 1.21 (1.01-1.45) 
 
P value for differences in CV events by presence/absence of CDH= <0.0001 
P value for interaction term added to model 6= 0.6449 
The analysis included women with complete data (n=43,708) 
Hazard ratios (HR) are reported with 95% confidence intervals.  
Chronic disease history is defined as history of chronic disease reported before year 5 including 
cancer (except non-melanoma skin cancer), diabetes, liver disease, kidney dialysis, asthma, 
emphysema, lupus, Alzheimer disease, MS, Parkinson disease, ALS. 
CV – cardiovascular  
CDH – chronic disease history 
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WHI OS (n=93,676) 
Ineligible for this analysis: (n=21,044) 
• Missing spirituality assessment data 
(n=755) 
• No follow-up after YR5 (n=629) 
• History of CV disease before YR5 
(n=19,660) 
 
Eligible sample (n=61,370) 
Data available for analysis 
(n= 43,708) 
Missing data on covariates (n=17,662)  
Returned YR5 spirituality assessment (n=82,414) 
Figure 1 
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Figure 2 
 
 
 
 
